创新医疗涨2.09%，成交额4.36亿元，主力资金净流入948.33万元

Core Viewpoint - Innovation Medical's stock has shown significant volatility, with a year-to-date increase of 157.54%, but recent declines in the short term indicate potential market fluctuations [1][2]. Group 1: Stock Performance - On September 29, Innovation Medical's stock rose by 2.09%, reaching 20.50 CNY per share, with a trading volume of 4.36 billion CNY and a turnover rate of 5.17%, resulting in a total market capitalization of 90.46 billion CNY [1]. - Year-to-date, the stock has increased by 157.54%, but it has decreased by 4.78% over the last five trading days and 18.62% over the last 20 days, while showing a 35.14% increase over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" 18 times this year, with the most recent appearance on September 5, where it recorded a net buy of -1.21 billion CNY [1]. Group 2: Financial Performance - For the first half of 2025, Innovation Medical reported a revenue of 402 million CNY, reflecting a year-on-year decrease of 1.60%, while the net profit attributable to the parent company was -11.36 million CNY, showing a year-on-year increase of 29.12% [2]. - Since its A-share listing, the company has distributed a total of 55.87 million CNY in dividends, with no dividends paid in the last three years [2]. Group 3: Shareholder Information - As of June 30, the number of shareholders for Innovation Medical was 82,000, an increase of 20.38% from the previous period, with an average of 5,074 circulating shares per person, a decrease of 16.93% [2].